Effect of alemtuzumab in German patients with Multiple Sclerosis

Trial Profile

Effect of alemtuzumab in German patients with Multiple Sclerosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs Alemtuzumab (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms TREAT-MS
  • Most Recent Events

    • 16 Jun 2015 Trial design presented at 67th Annual Meeting of the American Academy of Neurology.
    • 16 Jun 2015 Full patient enrolment is expected to be completed by the end of 2016, according to an abstract presented at 67th Annual Meeting of the American Academy of Neurology.
    • 16 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top